• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Interferons: rationale for clinical trials in neoplastic disease.

作者信息

Borden E C

出版信息

Ann Intern Med. 1979 Sep;91(3):472-9. doi: 10.7326/0003-4819-91-3-472.

DOI:10.7326/0003-4819-91-3-472
PMID:382941
Abstract

Interferons, cell glycoproteins synthesized in response to viral infections and various nonviral inducers, have proved therapeutically effective for viral infections in experimental models and in humans. Current evidence suggests interferons may also prove effective as antitumor agents in humans. Potent effects on cellular function result from interferons. Cell surface structure and enzyme levels are altered. Immunologic responses thought to be important in tumor immunity are augmented. Interferons have antiproliferative effects on the replication of normal and neoplastic cells. Interferons are effective in animals against tumors of both viral and nonviral origin. Clinical trials in cancer have been limited by the availability and cost of human interferons. However, results in small numbers of patients have been encouraging. This paper review experimental and clinical findings regarding the rationale for use of interferons in neoplastic disease.

摘要

相似文献

1
Interferons: rationale for clinical trials in neoplastic disease.
Ann Intern Med. 1979 Sep;91(3):472-9. doi: 10.7326/0003-4819-91-3-472.
2
Interferons: anti-neoplastic drugs?干扰素:抗肿瘤药物?
Blut. 1977 Sep 18;35(4):277-88. doi: 10.1007/BF00996140.
3
The interferons and their inducers: molecular and therapeutic considerations. 3.
N Engl J Med. 1972 Jul 20;287(3):122-8. doi: 10.1056/NEJM197207202870305.
4
Antitumor effects of interferon.干扰素的抗肿瘤作用。
Adv Cancer Res. 1972;16:97-140. doi: 10.1016/s0065-230x(08)60339-5.
5
Interferons and cancer.干扰素与癌症。
J Natl Cancer Inst. 1978 Jun;60(6):1191-4. doi: 10.1093/jnci/60.6.1191.
6
The role of interferons in the treatment of osteosarcoma.干扰素在骨肉瘤治疗中的作用。
Pediatr Blood Cancer. 2010 Mar;54(3):350-4. doi: 10.1002/pbc.22136.
7
Interferon and cancer: therapeutic prospects.干扰素与癌症:治疗前景
Rev Eur Etud Clin Biol. 1970 Jan;15(1):23-7.
8
[Interferons].
Ugeskr Laeger. 1977 Feb 14;139(7):411-2.
9
[Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects].[人干扰素的抗肿瘤活性:其直接细胞毒性活性及临床效果]
Gan No Rinsho. 1983 May;29(6):589-97.
10
Does interferon cure cancer?干扰素能治愈癌症吗?
Br Med J. 1980 Sep 27;281(6244):855-8. doi: 10.1136/bmj.281.6244.855.

引用本文的文献

1
Pulmonary arterial hypertension associated with interferon therapy: a population-based study.与干扰素治疗相关的肺动脉高压:一项基于人群的研究。
Multidiscip Respir Med. 2017 Jan 17;12:1. doi: 10.1186/s40248-016-0082-z. eCollection 2017.
2
Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study.五日输注氟脱氧尿苷联合口服亚叶酸钙及递增剂量的干扰素α-2b:一项I期研究。
Cancer Chemother Pharmacol. 1993;32(5):347-52. doi: 10.1007/BF00735917.
3
Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.
递增剂量的干扰素α-2A联合顺铂及同步放疗:一项I期研究。
Cancer Chemother Pharmacol. 1993;33(3):203-9. doi: 10.1007/BF00686217.
4
Stem cell assays in the evaluation of myelotoxicity.用于评估骨髓毒性的干细胞检测方法。
Environ Health Perspect. 1981 Jun;39:51-8. doi: 10.1289/ehp.813951.
5
Activity of human leukocyte interferon in a human tumor cloning system.
Cancer Chemother Pharmacol. 1982;8(1):99-103. doi: 10.1007/BF00292879.
6
Multiple biological activities of homogeneous human alpha interferon.人α干扰素同质性的多种生物学活性
Infect Immun. 1981 Dec;34(3):1068-70. doi: 10.1128/iai.34.3.1068-1070.1981.
7
The interferon renaissance: molecular aspects of induction and action.干扰素的复兴:诱导与作用的分子层面
Microbiol Rev. 1981 Jun;45(2):244-66. doi: 10.1128/mr.45.2.244-266.1981.
8
The toxicity of recombinant human interleukin-2 in rats following intravenous infusion.重组人白细胞介素-2静脉输注后在大鼠体内的毒性
J Natl Med Assoc. 1987 May;79(5):537-41.
9
A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer.
Cancer Chemother Pharmacol. 1986;18(1):63-8. doi: 10.1007/BF00253067.
10
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies.
J Neurooncol. 1985;3(1):61-7. doi: 10.1007/BF00165173.